Radiographic Outcomes Were Associated with Pain and Function Responses: Post-Hoc Analysis of Results from a Phase 2 Study of a Small Molecule Wnt Pathway Inhibitor, SM04690, for Knee Osteoarthritis Treatment

被引：0

作者：

Yazici, Yusuf ^{[1
]}

McAlindon, Timothy E. ^{[2
]}

Gibofsky, Allan ^{[3
,4
]}

Lane, Nancy E. ^{[5
]}

Skrepnik, Nebojsa ^{[6
]}

Armas, Eddie ^{[7
]}

Swearingen, Christopher J. ^{[1
]}

DiFrancesco, Anita ^{[1
]}

Tambiah, Jeymi ^{[1
]}

Hochberg, Marc ^{[8
,9
]}

机构：

[1] Samumed LLC, San Diego, CA USA

[2] Tufts Med Ctr, Div Rheumatol, Boston, MA USA

[3] Weill Cornell Med, Rheumatol, New York, NY USA

[4] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA

[5] Univ Calif Davis, Sch Med, Ctr Musculoskeletal Hlth, Sacramento, CA 95817 USA

[6] Tuscon Orthoped Inst, Tucson, AZ USA

[7] Well Pharma Med Res, Miami, FL USA

[8] Univ Maryland, Sch Med, Div Rheumatol & Clin Immunol, Baltimore, MD 21201 USA

[9] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1204

引用

页数：2

共 50 条

[31] THE NOVEL, INTRA-ARTICULAR CLK/DYRK1A INHIBITOR LORECIVIVINT (LOR; SM04690), WHICH MODULATES THE WNT PATHWAY, IMPROVED RESPONDER OUTCOMES IN SUBJECTS WITH KNEE OSTEOARTHRITIS: A POST HOC ANALYSIS FROM A PHASE 2B TRIAL
Yazici, Yusuf
Kennedy, Sarah
Swearingen, Christopher I.
Tambiah, Jeyanesh
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 120 - 121
[32] CLINICAL OUTCOMES FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, INTRA-ARTICULAR, INJECTABLE, WNT PATHWAY INHIBITOR (SM04690) FOR THE TREATMENT OF KNEE OSTEOARTHRITIS: WEEK 26 INTERIM ANALYSIS
Yazici, Y.
Gibofsky, A.
Lane, N. E.
Skrepnik, N.
Armas, E.
Swearingen, C. J.
DiFrancesco, A.
Tambiah, J. R.
McAlindon, T. E.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 985 - 986
[33] TREATMENT OF KNEE OSTEOARTHRITIS WITH SM04690 IMPROVED WOMAC A1 'PAIN ON WALKING' RESULTS FROM A 52 WEEK, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, INTRA-ARTICULAR, WNT PATHWAY INHIBITOR
Kennedy, S.
Ghandehari, H.
Swearingen, C.
Tambiah, J.
Hochberg, M.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 81 - 82
[34] Treatment of Knee Osteoarthritis with SM04690 Improved WOMAC A1 "Pain on Walking" - Results from a 52-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of a Novel, Intra-Articular, Wnt Pathway Inhibitor
Tambiah, Jeyanesh
Kennedy, Sarah
Ghandehari, Heli
Swearingen, Christopher
Hochberg, Marc C.
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[35] Safety, Efficacy and Biomarker Outcomes of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee: Interim, Exploratory Analysis of Results from a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study
Yazici, Yusuf
McAlindon, Timothy E.
Fleischmann, Roy
Gibofsky, Allan
Lane, Nancy E.
Kivitz, Alan J.
Skrepnik, Nebojsa
Armas, Eddie
Swearingen, Christopher J.
DiFrancesco, Anita
Tambiah, Jeyanesh R. S.
Hood, John
Hochberg, Marc C.
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[36] Analysis of Pain and Function Components in Omeract-Oarsi Strict Responders from a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee
Strand, Vibeke
Swearingen, Christopher J.
Simsek, Ismail
DiFrancesco, Anita
Tambiah, Jeymi
Yazici, Yusuf
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[37] LORECIVIVINT (SM04690), AN INTRA-ARTICULAR, SMALL-MOLECULE CLK2/DYRK1A INHIBITOR THAT MODULATES THE WNT PATHWAY, AS A POTENTIAL TREATMENT FOR MENISCAL INJURIES
Seo, T.
Deshmukh, V.
Yazici, Y.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 416 - 417
[38] SAFETY, CLINICAL AND IMAGING OUTCOMES OF A NOVEL, INTRA-ARTICULAR, INJECTABLE, WNT INHIBITOR (SM04690) IN THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE: EXPLORATORY ANALYSIS OF RESULTS FROM A 24 WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1 STUDY
Yazici, Y.
McAlindon, T. E.
Fleischmann, R. M.
Gibofsky, A.
Lane, N. E.
Kivitz, A. J.
Majumdar, S.
Strand, V.
Swearingen, C. J.
DiFrancesco, A.
Tambiah, J.
Hood, J.
Hochberg, M. C.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 826 - 826
[39] Assessment of Health-Related Quality of Life in a 52-Week, Phase 2, Randomized, Controlled Trial of a Novel, Intra-Articular, Wnt Pathway Inhibitor (SM04690) for Treatment of Knee Osteoarthritis
Strand, Vibeke
Ghandehari, Heli
Swearingen, Christopher
Tambiah, Jeyanesh
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[40] OMERACT-OARSI 'STRICT RESPONDERS' ANALYSIS FROM RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1 STUDY OF A NOVEL, INTRA-ARTICULAR, INJECTABLE, WNT INHIBITOR (SM04690) IN THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE
Yazici, Y.
Tambiah, J.
Swearingen, C. J.
DiFrancesco, A.
Strand, V.
OSTEOARTHRITIS AND CARTILAGE, 2016, 24 : S187 - S187

← 1 2 3 4 5 →